FDA explains withdrawal of anti-obesity drugs

MLA

Faigen, Nancy. “FDA Explains Withdrawal of Anti-Obesity Drugs.” SCRIP World Pharmaceutical News, no. 2270, Sept. 1997, p. 20. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.19846103&authtype=sso&custid=ns315887.

APA

Faigen, N. (1997, September 26). FDA explains withdrawal of anti-obesity drugs. SCRIP World Pharmaceutical News, 2270, 20.

Chicago

Faigen, Nancy. 1997. “FDA Explains Withdrawal of Anti-Obesity Drugs.” SCRIP World Pharmaceutical News, September 26. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.19846103&authtype=sso&custid=ns315887.